Send Your Enquiry
About Dr. Burhan Ferhanoglu
- Dr. Burhan Ferhanoğlu is a hematologist with 40+ years of experience.
- He is a member of the Turkish Society of Hematology, International Society of Hematology, European Hematology Association, American Society of Hematology and European Bone Marrow Transplantation Society.
- He graduated from Istanbul University, Istanbul in 1978, completed his residency in internal medicine from Istanbul University, Istanbul in 1982 and fellowship in hematology from Istanbul University, Istanbul in 1988.
- Dr. Burhan has conducted studies at the department of hematology and oncology at the University of Texas in 1990 and 1991.
- He made investigations at the Bone Marrow Transplantation Unit of Fred Hutchinson Cancer Research Center, Seattle in 1992.
- He has bagged many awards due to his contribution in the medical field.
Location
Graduation, Istanbul University, Istanbul(1978)- Fellowship, Fellowship, Istanbul University, Istanbul(1988)
• Second rank award in Turkish Society of Hematology 32nd National Hematology Congress, Antalya, 2006
• Best abstract award in “4th Aegean Hematology-Oncology Symposium”, Rhodes, Greece, September 21-24, 2017
• Roche Non-Hodgkin Lymphoma” award. (Turkish Society of Hematology Roche Industry Award) in the Turkish Society of Hematology 32nd National Hematology Congress, Antalya, 2006.
• “TSH Clinical Laboratory Hematology” award in Turkish Society of Hematology 30th National Hematology Congress, İstanbul, 2003.
- Professor, Istanbul University, Istanbul(2012)
- Observer, University of Texas, Texas(1991)
- Associate Professor, Istanbul University, Istanbul(1994)
- Visiting Consultant, Çorum State Hospital, Çorum(1986)
- Visiting Consultant, Bursa Military Hospital, Bursa(1984)
- Senior Resident, Istanbul University, Istanbul(1982)
Papers Published
Book chapters:
+ Read More- Show Less
- Ferhanoglu B, Ozbalak M. Diffüz Büyük B Hücreli Lenfoma (Article published in Turkish, Title: Diffuse Large B Cell Lymphoma). Ed. Teoman Soysal HematoLog-Special Issue on Lymphoma. 2013; 3(2): 355-81.
- Ferhanoglu B, Ozbalak M. Primer Merkezi Sinir Sistemi Lenfomaları (Article published in Turkish, Title: Primary Central Nervous System Lymphomas). Ed. Teoman Soysal HematoLogSpecial Issue on Lymphoma. 2013; 3(2): 382-94.
- Burhan Ferhanoğlu, “Anemia: Definition-Classification, Hematology Course Book” University Issue Nr.: 4774, Cerrahpaşa School of Medicine Issue Nr.: 269, ISBN: 978-975- 404-815-5, page: 21-26, 2008.
Articles Published in International Journals:
- Ozyigit LP, Aktas EC, Senbas ZA, Ozturk AB, Ozturk E, Ergonul MO, Tabak L, Ferhanoglu B, Cetiner M, Deniz G. The role of atopy in the pathogenesis of bleomycin pulmonary toxicity. Respiratory medicine. 2019; 155: 1-5.
- Younes A, Brody J, Carpio C, Lopez-Guillermo A, Ben-Yehuda D, Ferhanoglu B, Nagler A, Ozcan M, Avivi I, Bosch F, Caballero Barrington MD, Hellmann A, Kuss B, Ma DDF, Demirkan F, Yagci M, Horowitz NA, Marlton P, Cordoba R, Wrobel T, Buglio D, Streit M, Hodkinson BP, Schaffer M, Alvarez J, Ceulemans R, Balasubramanian S, de Jong J, Wang SS, Fourneau N, Jurczak W. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed nonHodgkin lymphoma or chronic lymphocytic leukemia: a phase 1/2a study. The Lancet Haematology. 2019; 6(2): e67-e78
- Ferhanoglu B, Ozturk E, Ozbalak M. Venetoclax-Rituximab in Chronic Lymphocytic Leukemia. The New England journal of medicine. 2018; 378(22): 2141-2.
- Ozturk E, Akay MO, Ferhanoglu B. Recognizing Pinch Purpura as the First Manifestation of Light-chain Amyloidosis. Turk J Haematol. 2018; 35(3): 208-9.
International Conference Presentations:
- Ferhanoğlu B, Beköz H, Karadurmuş N, Paydaş S, Türker A, Toptaş T, Fıratlı Tuğlular T, Sönmez M, Gülbaş Z, Özbalak M; “Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience” Poster Session in 4th Aegean Hematology-Oncology Symposium”, Rhodes, Greece, September 21-24, 2017
- Erbilgin Y, Eskazan AE, Hatirnaz Ng O, Salihoglu A, Elverdi T, Firtina S Catal Tatonyan S, Ongoren Aydin S, Ar MC, Baslar Z, Sayitoglu M, Ferhanoglu B, Aydin Y, Ozbek U, Soysal T Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance. 53rd ASH Annual Meeting and Exposition, Oral Session, Abstract No:384, December 7-10, 2013, Louisiana, New Orleans, USA.
- Murat OZBALAK, Ilyas Tokatlı, Metin Özdemirli, Tulay Tecimer, M. Cem Ar, Serdar Örnek, Aykut Koroglu, Yahya Laleli & Burhan Ferhanoglu. 2013b. IS VALGANCICLOVIR REALLY EFFECTIVE IN PRIMARY EFFUSION LYMPHOMA?: CASE REPORT OF AN HIV(-) EBV(-) HHV8(+) PATIENT. Poster Presentation: In 4th International Congress of Leukemia-Lymphoma-Myeloma. Istanbul, Turkey
Send Your Enquiry
Fill in your details and our medical experts will contact you within 24 hours.
Want to consult the doctor?
Don't Ignore Your Health!
Other Top Hematologist In Istanbul
Chat
Prof. Dr. Gulsan Sucak
Hematologist
Medical Park, Bahcelievler Hospital, Istanbul · Istanbul
36+ years of experience
Prof. Dr. Buket Erel Del Castello
Paediatric Hematologist
Yeditepe University Healthcare Institutions, Istanbul · Istanbul
35+ years of experience
Dr. Nevin Yalman
Paediatric Hematologist
Yeditepe University Healthcare Institutions, Istanbul · Istanbul
39+ years of experience
FAQ's About Dr. Burhan Ferhanoglu
Where does Dr. Burhan Ferhanoglu practice?
Dr. Burhan Ferhanoglu practices at American Hospital, Istanbul
What is the specialty of Dr. Burhan Ferhanoglu?
Dr. Burhan Ferhanoglu specialty is Hematologist
What is the experience of Dr. Burhan Ferhanoglu?
Dr. Burhan Ferhanoglu is Hematologist with 44 years of experience.
Chat